130 related articles for article (PubMed ID: 28072593)
1. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tolppanen AM; Sund R; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2017 May; 32(3):135-141. PubMed ID: 28072593
[TBL] [Abstract][Full Text] [Related]
2. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Sund R; Tiihonen J; Hartikainen S; Taipale H
J Am Med Dir Assoc; 2017 Jan; 18(1):87.e15-87.e21. PubMed ID: 27847263
[TBL] [Abstract][Full Text] [Related]
3. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
[TBL] [Abstract][Full Text] [Related]
4. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2015 Jul; 30(4):202-8. PubMed ID: 26011780
[TBL] [Abstract][Full Text] [Related]
6. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
[TBL] [Abstract][Full Text] [Related]
7. Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland.
Taipale H; Särkilä H; Tanskanen A; Kurko T; Taiminen T; Tiihonen J; Sund R; Tuulio-Henriksson A; Saastamoinen L; Hietala J
JAMA Netw Open; 2020 Oct; 3(10):e2019029. PubMed ID: 33119104
[TBL] [Abstract][Full Text] [Related]
8. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland.
Karttunen N; Taipale H; Hamina A; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
Int J Geriatr Psychiatry; 2019 Feb; 34(2):280-288. PubMed ID: 30370943
[TBL] [Abstract][Full Text] [Related]
9. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.
Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S
CMAJ; 2017 Apr; 189(14):E519-E529. PubMed ID: 28396328
[TBL] [Abstract][Full Text] [Related]
10. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
[TBL] [Abstract][Full Text] [Related]
11. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study.
Tapiainen V; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
Acta Psychiatr Scand; 2018 Aug; 138(2):91-100. PubMed ID: 29851063
[TBL] [Abstract][Full Text] [Related]
12. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
[TBL] [Abstract][Full Text] [Related]
13. Incidence of stroke in people with Alzheimer disease: a national register-based approach.
Tolppanen AM; Lavikainen P; Solomon A; Kivipelto M; Soininen H; Hartikainen S
Neurology; 2013 Jan; 80(4):353-8. PubMed ID: 23284063
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study.
Sarycheva T; Lavikainen P; Taipale H; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
J Am Heart Assoc; 2018 Sep; 7(18):e009742. PubMed ID: 30371186
[TBL] [Abstract][Full Text] [Related]
15. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Alzheimers Dis; 2019; 68(1):127-136. PubMed ID: 30775987
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
[TBL] [Abstract][Full Text] [Related]
17. Long-term benzodiazepine use and risk of labor market marginalization in Finland: A cohort study with 5-year follow-up.
Taipale H; Tanskanen A; Kurko T; Taiminen T; Särkilä H; Tiihonen J; Sund R; Niemelä S; Saastamoinen L; Hietala J
Eur Psychiatry; 2024 Apr; 67(1):e34. PubMed ID: 38572545
[TBL] [Abstract][Full Text] [Related]
18. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
19. Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.
Tolppanen AM; Voutilainen A; Taipale H; Tanskanen A; Lavikainen P; Koponen M; Tiihonen J; Hartikainen S
PLoS One; 2017; 12(3):e0173450. PubMed ID: 28278245
[TBL] [Abstract][Full Text] [Related]
20. 30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer's Disease.
Heiskanen J; Hartikainen S; Roine RP; Tolppanen AM
J Alzheimers Dis; 2015; 48(1):241-9. PubMed ID: 26401944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]